Only 3 studies of the colorectal cancer patients in our analysis had a KRAS codon 61 mutations [26, 67, 68] which is not surprising given that the majority of KRAS mutations reported in human tumours are in codon 12, with mutations in codons 13 and 61 accounting for only 1.7-9 percent [27]. The gene discussed is KRAS; the disease is neoplasm.